US neurobehavioral health company BlackThorn raises $76m to advance AI-driven targeted therapeutics
California-based neurobehavioral health company BlackThorn Therapeutics has raised $76 million through a Series B financing round to advance targeted therapeutics using the next-generation artificial intelligence (AI) technologies. The new investors in BlackThorn Therapeutics are Polaris Partners, Premier Partners, Vertex Ventures HC, and Scripps Research. Existing investors Alexandria Venture Investments, Johnson & Johnson Innovation, Altitude Life […]